OIC Part 1: Recommendations on Initiating Prescription Therapies for Opioid-Induced Constipation
WebcastOVERVIEW
OIC Part 1: Recommendations on Initiating Prescription Therapies for Opioid-Induced Constipation is organized by American Academy of Pain Medicine (AAPM) and will be held from Apr 20, 2016 - Apr 20, 2019.
The target audience for this medical event is Recommendations on Initiating Prescription Therapies for Opioid-Induced Constipation enduring virtual seminars (webinars) are designed for clinicians and all healthcare practitioners involved in the treatment of patients in pain. This educational initiative was planned and facilitated by leaders and experts from the American Academy of Pain Medicine (AAPM). AAPM is the leading medical association representing physicians committed to advancing the emerging science and practice of pain medicine. This program is designed to improve access to quality, evidence-based multidisciplinary pain care across the healthcare continuum. This CME Conference has been approved for a maximum of 1.25 AMA PRA Category 1 Credits.
Course Objectives:
• Define opioid-induced constipation.
• Identify selected factors to consider before evaluating patients’ potential need for OIC treatment using a validated assessment tool.
• Identify optimal treatment strategies for patients with OIC.
• Categorize various medication options to treat OIC.
• Match the mechanism to each drug class and medication discussed.
Additional details will be posted as soon as they are available.
The target audience for this medical event is Recommendations on Initiating Prescription Therapies for Opioid-Induced Constipation enduring virtual seminars (webinars) are designed for clinicians and all healthcare practitioners involved in the treatment of patients in pain. This educational initiative was planned and facilitated by leaders and experts from the American Academy of Pain Medicine (AAPM). AAPM is the leading medical association representing physicians committed to advancing the emerging science and practice of pain medicine. This program is designed to improve access to quality, evidence-based multidisciplinary pain care across the healthcare continuum. This CME Conference has been approved for a maximum of 1.25 AMA PRA Category 1 Credits.
Course Objectives:
• Define opioid-induced constipation.
• Identify selected factors to consider before evaluating patients’ potential need for OIC treatment using a validated assessment tool.
• Identify optimal treatment strategies for patients with OIC.
• Categorize various medication options to treat OIC.
• Match the mechanism to each drug class and medication discussed.
Additional details will be posted as soon as they are available.
SPECIALITIES
Pain MedicineGastroenterology
Quick Links